HELICOBACTER 2020 10.1111/hel.12685
Annual eradication rate of bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: A 15-year prospective study at a tertiary hospital in Korea
Yoon1, K; Kim, N; Lee, JW; Yoon, H; Shin, CM; Park, YS; Lee, DH

INFLAMM BOWEL DIS 2020 10.1093/ibd/izz317
Novel Histone Deacetylase 6 Inhibitor CKD-506 Inhibits NF-kappa B Signaling in Intestinal Epithelial Cells and Macrophages and Ameliorates Acute and Chronic Murine Colitis
Lee1, JW; Lee, SM; Chun, J; Im, JP; Seo, SK; Ha, N; Choi, YI; Kim, JS

THER ADV MED ONCOL 2020 10.1177/1758835920926796
First-in-human phase I trial of anti-hepatocyte growth factor antibody (YYB101) in refractory solid tumor patients
Kim1, ST; Hong, JY; Park, SH; Park, JO; Park, YW; Park, N; Lee, H; Hong, SH; Lee, SJ; Song, SW; Kim, K; Park, YS; Lim, HY; Kang, WK; Nam, H; Lee, JW; Park, K; Kim, KM; Lee, J

J CONTROL RELEASE 2020 10.1016/j.jconrel.2020.02.013
KSP siRNA/paclitaxel-loaded PEGylated cationic liposomes for overcoming resistance to KSP inhibitors: Synergistic antitumor effects in drug-resistant ovarian cancer
Lee1, J; Cho, YJ; Lee, JW; Ahn, HJ

Front Oncol 2020 10.3389/fonc.2020.00451
Comparison of Laparoscopy and Laparotomy for Para-Aortic Lymphadenectomy in Women With Presumed Stage I-II High-Risk Endometrial Cancer
Paik1, ES; Baek, SH; Kang, JH; Jeong, SY; Kim, MS; Kim, WY; Lee, YY; Choi, CH; Lee, JW; Kim, BG; Bae, DS; Kim, TJ

J CLIN MED 2020 10.3390/jcm9041137
Identification of Candidate Genes Associated with Susceptibility to Ovarian Clear Cell Adenocarcinoma Using cis-eQTL Analysis
Kim1, J; Chung, JY; Hwang, JR; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH; Hewitt, SM

CANCER RES TREAT 2020 10.4143/crt.2019.328
Pretreatment Lymph Node Metastasis as a Prognostic Significance in Cervical Cancer: Comparison between Disease Status
Jeong1, SY; Park, H; Kim, MS; Kang, JH; Paik, ES; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH

J GYNECOL ONCOL 2020 10.3802/jgo.2020.31.e15
Real world effectiveness and safety of pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian, fallopian, or primary peritoneal cancer: a Korean multicenter retrospective cohort study
Park1, SJ; Kim, J; Kim, HS; Lee, JW; Chang, H; Lee, KH; Kim, DY; Kim, S; Chang, SJ; Han, SS; Park, SY; Shim, SH

J BIOMED NANOTECHNOL 2020 10.1166/jbn.2020.2883
Selective Tumor-Specific Antigen Delivery to Dendritic Cells Using Mannose-Labeled Poly(d,l-lactide-co-glycolide) Nanoparticles for Cancer Immunotherapy
Wi1, TI; Byeon, Y; Won, JE; Lee, JM; Kang, TH; Lee, JW; Lee, YJ; Sood, AK; Han, HD; Park, YM

J MINIM INVAS GYN 2020 10.1016/j.jmig.2019.04.005
In Vivo Comparison of MONOFIX, A Novel Barbed Suture with a Triangular Stopper, with Pre-existing Products in a Porcine Model
Kim1, J; Eom, HJ; Shin, H; Jeong, SY; Kim, MS; Yoon, HS; In, CH; Kim, BG; Bae, DS; Lee, JW

J CLIN MED 2020 10.3390/jcm9010147
Phase I Study of a B Cell-Based and Monocyte-Based Immunotherapeutic Vaccine, BVAC-C in Human Papillomavirus Type 16-or 18-Positive Recurrent Cervical Cancer
Choi1, CH; Choi, HJ; Lee, JW; Kang, ES; Cho, D; Park, BK; Kim, YM; Kim, DY; Seo, H; Park, M; Kim, W; Choi, KY; Oh, T; Kang, CY; Kim, BG

BIOCHEM PHARMACOL 2020 10.1016/j.bcp.2019.113735
Cytoplasmic expression of EGFR shRNA using a modified T7 autogene-based hybrid mRNA/DNA system induces long-term EGFR silencing and prolongs antitumor effects
Seraj1, S; Cho, YJ; Lee, JW; Ahn, HJ

GYNECOL ONCOL 2020 10.1016/j.ygyno.2019.11.004
CDK7 is a reliable prognostic factor and novel therapeutic target in epithelial ovarian cancer
Kim1, J; Cho, YJ; Ryu, JY; Hwang, I; Han, HD; Ahn, HJ; Kim, WY; Cho, H; Chung, JY; Hewitt, SM; Kim, JH; Kim, BG; Bae, DS; Choi, CH; Lee, JW

J Minim Invasive Gynecol. 2019 Apr 6. pii: S1553-4650(19)30154-2. doi: 10.1016/j.jmig.2019.04.005. [Epub ahead of print]
In Vivo Comparison of MONOFIX, A Novel Barbed Suture with a Triangular Stopper, with Pre-existing Products in a Porcine Model
Kim J1, Eom HJ, Shin H, Jeong SY, Kim MS, Yoon HS, In CH, Kim BG, Bae DS, Lee JW.

J Gynecol Oncol. 2019 Jul;30(4):e65. doi: 10.3802/jgo.2019.30.e65. Epub 2019 Mar 11.
Prediction of Survival Outcomes in Patients with Epithelial Ovarian Cancer using Machine Learning Methods
E Sun Paik1, Jeong-Won Lee, Jeong-Yeol Park, Ju-Hyun Kim, Mijung Kim, Tae-Joong Kim, Chel Hun Choi, Byoung-Gie Kim, Duk-Soo Bae, Sung Wook Seo

Genome Biol. 2019 Nov 26;20(1):253. doi: 10.1186/s13059-019-1848-3.
Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers
Sa JK1, Hwang JR, Cho YJ, Ryu JY, Choi JJ, Jeong SY, Kim J, Kim MS, Paik ES, Lee YY, Choi CH, Kim TJ, Kim BG, Bae DS, Lee Y, Her NG, Shin YJ, Cho HJ, Kim JY, Seo YJ, Koo H, Oh JW1, Lee T, Kim HS, Song SY, Bae JS, Park WY, Han HD, Ahn HJ, Sood AK, Rabadan R, Lee JK, Nam DH, Lee JW.

Obstet Gynecol Sci. 2019 Mar;62(2):103-111. doi: 10.5468/ogs.2019.62.2.103. Epub 2019 Feb 12
Prognostic factors for recurrence and survival in uterine leiomyosarcoma: Korean single center experience with 50 cases
E Sun Paik1, Jae Hong Kang, Jihye Kim, Yeon-Joo Lee, Chel Hun Choi, Tae-Joong Kim, Byoung-Gie Kim, Duk-Soo Bae, Jeong-Won Lee

J OVARIAN RES 2019 10.1186/s13048-019-0602-5
Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer
Jeong1, SY; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Lee, YY

SCI REP-UK 2019 10.1038/s41598-019-51959-3
Anti-Tumor Effects of Wee1 Kinase Inhibitor with Radiotherapy in Human Cervical Cancer
Lee1, YY; Cho, YJ; Shin, SW; Choi, C; Ryu, JY; Jeon, HK; Choi, JJ; Hwang, JR; Choi, CH; Kim, TJ; Kim, BG; Bae, DS; Park, W; Lee, JW
외 다수